Skip to main content
. 2018 Dec 11;38(6):BSR20181693. doi: 10.1042/BSR20181693

Figure 3. Shikonin regulated PI3K/Akt signaling pathway of afatinib-resistant NSCLC cell lines.

Figure 3

(A) Shikonin increased the expression of cleaved caspase-3 and Bax, while decreased Bcl-2 expression of H1650/R and H1975/R cells compared with control group. (B) Shikonin down-regulated the expressions of p-PI3K, p-Akt of H1650/R and H1975/R cells compared with control group. *Statistically significant difference compared with control group (P<0.05).